Flow cytometric analysis of C57BL/6 mouse splenocytes treated 48h with 2.5 μg/ml Concanavalin A (Right panel) or untreated (Left panel), labeling CD134 at 1/200 dilution (1 μg). Goat Anti - Rat IgG Alexa Fluor® 647 was used as the secondary antibody. Then cells were stained with CD3 - Phycoerythrin antibody separately.
Product Details
Product Details
Product Specification
Host | Rat |
Antigen | CD134 |
Synonyms | Tumor necrosis factor receptor superfamily member 4; OX40 antigen; OX40L receptor; Ox40; Txgp1; Tnfrsf4 |
Location | Membrane |
Accession | P47741 |
Clone Number | S-R711 |
Antibody Type | Rat mAb |
Isotype | IgG1,k |
Application | FCM |
Reactivity | Ms |
Positive Sample | C57BL/6 mouse splenocytes treated 48h with 2.5 μg/ml Concanavalin A |
Purification | Protein G |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application | dilution | species |
FCM | 1:200 | Ms |
Background
CD134, also known as TNFRSF4 or OX40, is a member of the tumor necrosis factor receptor superfamily. It is a co-stimulatory molecule primarily expressed on activated CD4+ and CD8+ T cells, as well as other immune cells such as natural killer (NK) cells and dendritic cells. Structurally, CD134 contains four TNFR-Cys repeats and interacts with its ligand, OX40L (TNFSF4), to activate downstream signaling pathways, including the NF-κB pathway through adaptor proteins like TRAF2 and TRAF5. This interaction promotes T cell proliferation, cytokine production, and enhances the survival of CD8+ T cells, playing a crucial role in immune responses. Additionally, CD134 has been implicated in various diseases, including cancer and autoimmune conditions, making it a target for immunotherapy and other therapeutic interventions.
Picture
Picture
FC
